帕西莎治疗公司(Pasithea Therapeutics Corp.)宣布,对其治疗方案进行了重要修正。根据最新调整,患者治疗周期将延长至18个月,并新增了核磁共振扫描与认知测量两项关键评估内容。这一系列修正旨在更全面地监测治疗效果与患者长期状况,为临床研究提供更为详尽的数据支持。
帕西莎治疗公司(Pasithea Therapeutics Corp.)宣布,对其治疗方案进行了重要修正。根据最新调整,患者治疗周期将延长至18个月,并新增了核磁共振扫描与认知测量两项关键评估内容。这一系列修正旨在更全面地监测治疗效果与患者长期状况,为临床研究提供更为详尽的数据支持。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.